col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


8 Results       Page 1

 [1] 
Elsevier: Journal of Pharmacological Sciences
  original article Date Title Authors   All Authors
1 [GO] 2023―Feb―15 Potential treatments of COVID-19: Drug repurposing and therapeutic interventions Pawan Kumar Raghav, Zoya Mann, Simran Kaur Ahluwalia, Dinesh Kumar
2 [GO] 2022―Jul―31 Characterization of serotonin as a candidate biomarker of severity and prognosis of COVID-19 using LC/MS analysis Kosuke Saito, Rika Ishikawa, Isao Kitamura, Kumiko Ogawa, Noriaki Arakawa, Yuchen Sun, et al. (+4)
3 [GO] 2022―Jun―15 Novel aspects of sepsis pathophysiology: NETs, plasma glycoproteins, endotheliopathy and COVID-19 M. Nishibori
4 [GO] 2022―Jun―13 Serum stratifin and presepsin as candidate biomarkers for early detection of COVID-19 disease progression Noriaki Arakawa, Shinichiro Matsuyama, Masaru Matsuoka, Isao Kitamura, Keiko Miyashita, Yutaro Kitagawa, et al. (+5)
5 [GO] 2022―May―03 SARS-CoV-2 induces barrier damage and inflammatory responses in the human iPSC-derived intestinal epithelium Shigeru Yamada, Takamasa Noda, Kaori Okabe, Shota Yanagida, Motohiro Nishida, Yasunari Kanda
6 [GO] 2022―Apr―26 Drug repurposing for the treatment of COVID-19 Yuri Kato, Kazuhiro Nishiyama, Akiyuki Nishimura, Takamasa Noda, Kaori Okabe, Takahiro Kusakabe, et al. (+2)
7 [GO] 2022―Apr―18 Antiviral activity of ciclesonide acetal derivatives blocking SARS-CoV-2 RNA replication Genichiro Tsuji, Shogo Nakajima, Koichi Watashi, Shiho Torii, Rigel Suzuki, Takasuke Fukuhara, et al. (+3)
8 [GO] 2021―May―23 Computational study of the therapeutic potentials of a new series of imidazole derivatives against SARS-CoV-2 Titilayo O. Johnson, Abayomi Emmanuel Adegboyega, Opeyemi Iwaloye, Omokehinde Abiodun Eseola, Winfried Plass, Boluwatife Afolabi, et al. (+5)
 [1] 

8 Results       Page 1



[de][en]

Last change 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.004 sec